$Astellas Pharma (4503.JP)$
Astellas has been approved in the United States as a treatment for age-related macular degeneration, which causes poor eyesight.
As a result, the stock price went up a lot 😊
When it comes to age-related macula, it damages the retina and leads to poor eyesight.
What suppresses that damage is this medicine, and it's a very new drug 😊
Astellas had ophthalmology-related research and acquisitions of related companies for a long time, so I was really looking forward to it 😊
Moreover, eye diseases are in demand by many people, and I think they will be closely related to everyday life in the future, like lifestyle diseases 😊
So, it's strong to be able to monopolize this field for a while with this new drug 😊
Since stable profits can also be made, I think shareholder returns will also be actively promoted 😊
I really want companies that develop drugs for such intractable diseases to do their best, and I want to support them 👍
I want to keep getting really excited 😊

$Ryohin Keikaku (7453.JP)$
Ryohin Keikaku raised the stock price by 20% or more today 🙌
The reason is
Operating revenue for the third quarter was 1.2 times the same period last year
Operating profit was 2.1 times the same period last year
and the increase in sales and profit is a factor 🥹
From this, large investors made a lot of purchases, which led to a major rise in stock prices.
Conversely, it is also characteristic that individual investors are in the sale 🤔
There are quite a lot of people who have made a profit 🤔
Since the Chinese market has revived,
Maybe we can look forward to it in the future 🙌
If you find it helpful, please comment 🥹

The pharmaceutical industry declined across the board yesterday.
The reason is that the results of drugs developed by Daiichi Sankyo for lung cancer were not effective.
As a result, the pharmaceutical industry began to sell,
Overall, it began to decline.
However, personally, I would like to steadily invest in excellent stocks at this timing 🥰
What I'm paying attention to right now
$Astellas Pharma (4503.JP)$
Biopharmaceuticals are strong, and they are particularly resistant to cancer.
Recently, I've been focusing on eye treatment, and I'm personally paying attention to it in the future.
$Santen Pharmaceutical (4536.JP)$
A company with strengths in ophthalmic drugs.
We started a deficit last year, but since there doesn't seem to be any worse material, I'm looking forward to the future.
$Chugai Pharmaceutical (4519.JP)$
This is also a manufacturer with strong biopharmaceuticals
My finances are pretty good and I want to hold it for a long time.
I'd like to keep checking these out 🥰
Please also tell me the brands everyone is aiming for 🥰

$Nippon Telegraph & Telephone (9432.JP)$
Nippon Telegraph and Telephone raised its stock price by 5% today 🎊
Since the Nikkei Average has also risen by 600 yen or more, many Japanese stocks have also risen across the board.
It's important to invest not to worry about stock prices, buy more steadily, and just sit back and see 🤔
I'll keep watching 🤔

$Ya-Man (6630.JP)$
Yahman is a company that sells facial equipment items, and shareholder benefits are really hot 🥹
Normally it's 5,000 yen, but it has been upgraded to a discount of up to 13,000 yen for long-term holdings 😍
If you make a contract for 1000 yen, the yield will be a whopping 13% 🤣🤣🤣
It's a very reasonable discount, and in the future, masks will come off, demand for beauty will increase, and demand from foreigners is likely to increase, so I'm expecting it 😍
I will do my best to hold it for a long time for my future wife 🤣

Interest rate hikes remained unchanged at the FOMC in June 🤔
The Bank of Japan also continues monetary easing, and the depreciation of the yen progresses 😳 $USD/JPY (USDJPY.FX)$
The S&P 500 is also rising steadily 🙌
$E-mini S&P 500 Futures(SEP4) (ESmain.US)$
There weren't any big surprises this time, so stock prices are rising steadily, 🥰
Also, Chairman Powell said that interest rates will be raised 2 more times this year, so I wonder where that will happen 🤔
There is also a rumor that it's next month, but what do you think 🤔
what does everyone think?

$Okinawa Cellular Telephone (9436.JP)$
Okinawa Cellular special offers have arrived 😍
A catalog gift worth 3000 yen is too much fun 🥹
What is everyone going to do? 🥹

$Fujimi (5384.JP)$
Fujimi Incorporated is a company that manufactures and sells semiconductor silicon wafers and abrasives.
These materials are extremely important for improving the performance of semiconductors.
Furthermore, it is attractive that they are aggressive in overseas expansion, with an overseas sales ratio of 77% or more.
The financial results are also quite attractive. Sales and operating profit margins are also rising steadily.
The semiconductor market as a whole is declining in 2023, so it can't be helped.
Nonetheless, the ability to earn money is not inferior, and the fact that it has produced solid results is also an attractive point.
Because ROE and EPS also stretch pretty nicely
I'm looking forward to the future as well.
The capital adequacy ratio is also quite high, and if it exceeds 80%, will they go bankrupt? It's such an excellent company 😊
Dividends have been increasing all the time, and it looks like they will continue to increase in the future
Furthermore, since the stock will be split in July, I'm also happy that it will be easier to buy 😊
Fujimi's technology is an advanced technology that cannot be imitated by other companies, so it's one of the top global niche 😊
That's why we're making high profit margins without forcibly lowering prices 😊
Please use it as a reference ♪